ADIPOQ and Insulin resistance: The relative levels of these adipokines are such that they adversely affect insulin sensitivity; adiponectin improves insulin signaling, while resistin blocks it, thus leading to insulin resistance and facilitating the progression from MASLD to T2DM (193).